Amarin Corp Plc (AMRN)

[AGORDON]

On the one hand, there are competitors. A similar drug was approved last year. Chinese prefer homeopathic treatments. High triglyceride is a fraction of the market. No revenues until next year. On the other hand, fish oil is a substance that is not foreign to Chinese patients. No expensive salesforce to fund. Gross margin should improve next year.
Net positive.
Was Hong Kong approved for CVD?